Therapeutics Development

Objectively demonstrate the cognitive safety and efficacy of your treatments with our non-invasive and cost-effective clinical endpoint.

Therapeutics Safety

‌Our product platform allows researchers to easily monitor the cognitive health of study participants throughout the clinical trial process. Determining the cognitive safety of developmental drugs is integral to improving patient outcomes and reducing commercial risk.

Mitigate the risk of late-stage failure by proactively monitoring cognitive signals using our patient friendly and convenient assessment tools that will integrate seamlessly into research workflow.

Efficiency and Convenience

  • ‌‌Assess participants in-person or remotely
  • Patient-directed assessments for monitoring in between clinical visits
  • Detailed report generated immediately after assessments
  • Different assessment options to suit your study and participants
  • Comprehensive dashboard and normative data base to enable robust data analytics
  • Data visualization via tailored graphs and charts

Ready to take the next step? 

Get in touch with us to learn more

Our latest research

Working with the Mayo Clinic to understand Long-COVID

This study focuses on understanding the neurological impact of Long-COVID by developing a solution that assists clinicians and researches to better understand and address the impacts of this new and emerging phenomena.

Interested in working with us?

Get in touch with us below to learn more

Let's make the INVISIBLE effects of brain disorders VISIBLE, together.

BrainFx logo

Copyright © 2022 - BrainFx. All rights reserved.

Important Information: BrainFx Assessments only provide information about neurofunctional performance. Assessment results detail the patient/client's performance on assessment activities completed and only assist the health care team in identifying potential areas of strength or challenge as related to function. Assessments DO NOT provide any diagnosis or treatment recommendations. BrainFx Assessments are only permitted to be delivered by trained clinicians. Assessment reports are not stand-alone and require the interpretation of a health professional within their scope of practice and in the context of all information that they have gathered about their patient/client. In Canada, BrainFx Assessments are cleared by Health Canada as a Class 1 Software as a Medical Device. BrainFx Assessments and the statements made on this website have not been evaluated by any other regulatory bodies. Assessments are not intended to diagnose, treat, cure, or prevent any disease. Information provided by BrainFx is not a substitute for face-to-face consultation with your health care professional and should not be construed as individual medical advice.